3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow rolapitant: new trials by email Literature Review of rolapitant trials Research Report on rolapitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects Rolapitant, Digoxin, Sulfasalazine - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | Tesaro, Inc. | 102 | 2015-05-01 | 2015-08-25 |
| A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers Rolapitant - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | Tesaro, Inc. | 100 | 2015-01-01 | 2015-08-25 |
| An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant Rolapitant - Oral, Rolapitant - IV - Chemotherapy-induced Nausea and Vomiting | Phase 1 | Completed | Tesaro, Inc. | 138 | 2014-09-01 | 2015-08-25 |
Vomiting (3)
Tesaro, Inc. (3)
United States (3)
Dennis Vargo, MD (3)